Frontlight ResearchEarly access
Thyroid cancer trials in United States
51 of 76 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStudy of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
- Where
- Aberdeen, Allentown, Alma, Alpena, Alton, Anaconda, Anchorage, Ankeny, Ann Arbor, Atlanta, Aurora, Baker City, Ballwin, Baltimore, Barrington, Bellingham, Bemidji, Bend, Bethlehem, Bettendorf, Billings, Bismarck, Boise, Bolivar, Bozeman, Branson, Brighton, Burbank, Burlington, Burnsville, Caldwell, Cambridge, Canton, Cape Girardeau, Caro, Carroll, Cary, Cedar Rapids, Centralia, Chapel Hill, Charleston, Chaska, Chelsea, Cheyenne, Chicago, City of Saint Peters, Clackamas, Clarkston, Clive, Cody, Coeur d'Alene, Coon Rapids, Coos Bay, Council Bluffs, Creston, Creve Coeur, Crown Point, Crystal Lake, Cudahy, DeKalb, Derby, Des Moines, Detroit, Downers Grove, Durham, East China, East Stroudsburg, Eau Claire, Edina, Edmonds, Elgin, Emmett, Erie, Everett, Fairbanks, Fairfield, Fargo, Flint, Fort Dodge, Fort Lauderdale, Fort Smith, Franklin, Fruitland, Garden City, Geneva, Germantown, Gladwin, Glastonbury, Glenview, Grafton, Grand Rapids, Grayslake, Great Bend, Great Falls, Green Bay, Greenwich, Grosse Pointe Woods, Guilford, Hartford, Havre, Hazel Crest, Hazleton, Helena, Highlands Ranch, Hood River, Iowa City, Irvine, Issaquah, Jacksonville, Joplin, Kalispell, Kennewick, Kenosha, Lacey, Lake Forest, Lansing, Lawton, Lexington, Libertyville, Little Rock, Livonia, Longview, Macomb, Maple Grove, Maplewood, Marinette, Marlette, Marshfield, Meridian, Midland, Milwaukee, Minneapolis, Minocqua, Missoula, Monticello, Mount Pleasant, Mount Vernon, Muskegon, Nampa, Napa, Nashville, Newberg, New Haven, New Lenox, New Richmond, New Ulm, North Haven, Norton Shores, Oak Lawn, Oklahoma City, Omaha, Ontario, Orange, Oregon City, Orland Park, Osage Beach, Oshkosh, Palo Alto, Palos Heights, Park Ridge, Pella, Philadelphia, Pittsburg, Pittsburgh, Pontiac, Portland, Post Falls, Princeton, Racine, Raleigh, Redmond, Rice Lake, Robbinsdale, Rochester, Rolla, Saginaw, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, Sandpoint, Santa Rosa, Seattle, Sedro-Woolley, Shakopee, Sheboygan, Sheridan, Shiloh, Sioux Falls, Spokane, Springfield, Stamford, Stevens Point, Stillwater, St Louis, Summit, Tawas City, Thief River Falls, Torrington, Trumbull, Twin Falls, Two Rivers, Vancouver, Waconia, Walla Walla, Warren, Warrenville, Washington, Waterbury, Waterford, Waukee, Wauwatosa, West Allis, West Branch, West Des Moines, Westerly, Weston, Willmar, Woodbury, Worthington, Wyoming, Ypsilanti
- Age
- 18 years and over
- People
- 264
- Run by
- ECOG-ACRIN Cancer Research Group
See details and how to joinNCT06475989 - Phase 2Taking peopleComparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
- Where
- San Francisco
- Age
- 12 years and over
- People
- 62
- Run by
- Thomas Hope
See details and how to joinNCT06961084 - Phase 1/2Not yet taking people in United States177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 18
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT06991738 - Phase 2Taking peopleThe Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
- Where
- Bethesda
- Age
- 18 years to 98 years
- People
- 54
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT04927416 - Phase 1Taking peopleStudy of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- Where
- Houston
- Age
- 12 years to 50 years
- People
- 44
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT03093909 - Phase 1Taking peopleAn Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
- Where
- Houston
- Age
- 18 years and over
- People
- 42
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04589624 - No phaseTaking peopleNanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
- Where
- Houston, Sarasota
- Age
- 18 years and over
- People
- 15
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07218315 - No phaseTaking peopleEvaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- Where
- Duarte
- Age
- 18 years and over
- People
- 1,450
- Run by
- City of Hope Medical Center
See details and how to joinNCT05229341 - Phase 2Taking peopleZanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
- Where
- Ann Arbor, Boston, Charlottesville, Cleveland, Houston
- Age
- 18 years and over
- People
- 45
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06959511 - No phaseTaking peopleActive Surveillance of Papillary Thyroid Microcarcinoma
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 216
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT02609685 - Phase 3Taking peopleArtificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
- Where
- Nashville
- Age
- 18 years and over
- People
- 100
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT05999630 - Phase 2Taking peopleThe Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
- Where
- Bethesda
- Age
- 18 years to 90 years
- People
- 30
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT03841617 - Phase 3Enrolling by invitationLong-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Where
- Bay Shore, Houston, Kettering, Memphis
- People
- 5,000
- Run by
- Exelixis
See details and how to joinNCT07620574 · EU 2026-525795-26-00 - Phase 2Taking peopleLarotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
- Where
- Boston, Houston, Memphis, Philadelphia, San Francisco, Seattle
- Age
- 2 years to 99 years
- People
- 13
- Run by
- Children's Hospital of Philadelphia
See details and how to joinNCT05783323 - Phase 2Not yet taking people in United StatesPulsed Stereotactic Ablative Radiotherapy (PULSAR) With Systematic Therapy for Thyroid Cancer
- Where
- St Louis
- Age
- 18 years and over
- People
- 12
- Run by
- Washington University School of Medicine
See details and how to joinNCT07886905 - No phaseNot yet taking people in United StatesSTAGE-MTC Trial Thyroid Lobectomy With Ipsilateral Central Neck Dissection
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 100
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT07612293 - Phase 2Taking peopleA Study of Avutometinib and Defactinib in People With Thyroid Cancer
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 30
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06007924 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - No phaseNot yet taking people in United StatesPersonalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
- Where
- Ann Arbor
- Age
- 20 years to 39 years
- People
- 142
- Run by
- University of Michigan Rogel Cancer Center
See details and how to joinNCT07529080 - Phase 2Not yet taking people in United StatesZanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 12
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07470489 - Phase 1/2Taking peoplePhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Where
- Aurora, Boston, Cleveland, Durham, Fairfax, Gilbert, Grand Rapids, Houston, Los Angeles, Minneapolis, Nashville, New Haven, New York, San Antonio, San Francisco, Seattle, St Louis, Washington D.C.
- Age
- 18 years and over
- People
- 554 worldwide
- Run by
- Institut de Recherches Internationales Servier
See details and how to joinNCT05786924 · EU 2025-523474-16-00 - Phase 1Not yet taking people in United States211At-MABG in Adults With Advanced Neuroendocrine Cancers
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 16
- Run by
- University of Pennsylvania
See details and how to joinNCT07661420 - Phase 2Not yet taking people in United StatesEnfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma
- Where
- Chicago
- Age
- 18 years and over
- People
- 56
- Run by
- Northwestern University
See details and how to joinNCT07863765 - Phase 1/2Taking peopleRadiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Where
- Gilbert, Seattle, Tucson
- Age
- 18 years to 99 years
- People
- 30
- Run by
- University of Arizona
See details and how to joinNCT06814496 - Phase 1Taking peopleXL092 and Cemiplimab in BRAF WT Thyroid Cancer
- Where
- Boston, Chapel Hill
- Age
- 18 years and over
- People
- 12
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06902376